Immunomedics announces multiple clinical and preclinical collaborations with prominent cancer research institutions. Read More ...
Immunomedics typically recruits candidates directly rather than with the ... for us to review, please forward the relevant documentation to Immunomedics, Inc., ...
View the basic IMMU stock chart on Yahoo Finance. Change the date range, chart type and compare Immunomedics, Inc. against other companies.
Dec 6, 2017 ... After Immunomedics (NASDAQ:IMMU) shared some positive clinical data with investors, shares of the clinical-stage biotech focused on cancer ...
May 5, 2017 ... Immunomedics (NASDAQ:IMMU) is up 18% at 1:11 p.m. EDT after announcing a new plan to develop sacituzumab govitecan on its own, ...
Immunomedics Inc. financial and business news, updates, and information from The New York Times and other leading providers.
Jun 13, 2018 ... About: Immunomedics, Inc. (IMMU) ... Immunomedics (NASDAQ:IMMU) is a clinical-stage biotech pharmaceutical company specializing in ...
Immunomedics Inc. stock price, stock quotes and financial overviews from MarketWatch.
Learn about working at Immunomedics. Join LinkedIn today for free. See who you know at Immunomedics, leverage your professional network, and get hired.